News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
FDA Grants Orphan Drug Designation to Ultimovacs' UV1 Vaccine for Mesothelioma Treatment
Monday, October 09, 2023Ultimovacs ASA OSE ULTI a prominent biotechnology company specializing in innovative cancer vaccines has secured Orphan Drug Designation ODD from the US Food and Drug Administration FDA for their therapeutic cancer vaccine UV intended for the treatme...
FDA Approves Arcutis' ZORYVE® (Roflumilast) Cream 0.3% for Psoriasis Treatment in Children Ages 6 to 11
Saturday, October 07, 2023Arcutis Biotherapeutics Inc NASDAQ ARQT is an early commercialstage biopharmaceutical company with a focus on advancing innovations in immunodermatology
Abbvie Exercises Exclusive Option to Acquire Mitokinin, Enhancing Its Neuroscience Pipeline
Friday, October 06, 2023AbbVie NYSE ABBV has officially acquired Mitokinin a biotech firm in the discovery phase which has been working on a pioneering treatment for Parkinsons Disease PD
BIOVECTRA and Acuitas Therapeutics Enter Into Partnership for Unique Lipid Nanoparticle (LNP) Delivery System in the Production of MRNA-based Therapies
Friday, October 06, 2023BIOVECTRA and Acuitas Therapeutics Inc have announced a collaborative technology transfer service agreement BIOVECTRA will gain access to Acuitas advanced Lipid Nanoparticle LNP technology platform for manufacturing mRNAbased therapeutics on a nonexc...
Ankyra Therapeutics Enters Clinical Trial Collaboration and Supply Deal with Merck to Assess ANK-101 Alongside KEYTRUDA® in Advanced Solid Tumor Patients
Thursday, October 05, 2023Ankyra Therapeutics a clinical biotechnology company specializing in the development of a unique form of localized immunotherapy known as anchored immunotherapy has announced a collaboration and supply agreement for a clinical trial with Merck known...
Imidomics and Wuxi Biologics Enter Strategic Collaboration for Advancing IMB1001 Antibody Development in Immune-mediated Inflammatory Conditions
Thursday, October 05, 2023IMIDomics Inc has recently announced a strategic partnership with WuXi Biologics a global Contract Research Development and Manufacturing Organization This collaboration aims to expedite the development and manufacturing of IMIDomics IMB
Shasqi's Plans for Expanding Ongoing Research Collaboration to Enhance Targeted Cancer Treatment
Thursday, October 05, 2023Shasqi Inc a clinicalstage biotechnology company with a mission to enhance the efficacy of cancer drugs through click chemistry has recently announced the expansion of its ongoing research collaboration with Johnson Johnson Enterprise Innovation Inc
Willow and Suanfarma Collaborate to Enhance Development of High-volume Anti-infective API
Wednesday, October 04, 2023Willow Biosciences Inc TSX WLLW OTCQB CANSF and SUANFARMA have jointly revealed a collaboration agreement to enhance cell line productivity for the production of a highvolume antiinfective active pharmaceutical ingredient API through precision fermen...
Alvotech and Kashiv Biosciences Establish Exclusive Licensing Agreement for Development and Commercialization of Proposed Xolair® (Omalizumab) Biosimilar
Wednesday, October 04, 2023Alvotech NASDAQ ALVO and Kashiv Biosciences LLC have recently announced an exclusive licensing agreement for AVT also known as ADL a potential biosimilar to Xolair omalizumab which is currently undergoing clinical development
IAMA Therapeutics and Evotec Establish Multi-phase, Strategic Provider Agreement
Tuesday, October 03, 2023IAMA Therapeutics a pharmaceutical company dedicated to developing innovative medicines for children affected by brain disorders has recently announced a strategic collaboration with Evotec a company specializing in integrated drug development soluti...
